Pharmacyclics, Inc. Stock
Equities
US7169331060
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2015 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
2015 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 15-04-30 | |
Betty Chang
CTO | Chief Tech/Sci/R&D Officer | - | 13-07-08 |
Heow Tan
CTO | Chief Tech/Sci/R&D Officer | 65 | 12-04-30 |
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.84B | |
+46.90% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- Stock